<DOC>
	<DOCNO>NCT00231452</DOCNO>
	<brief_summary>The overall objective evaluate effect exposure Plasmodium ( P. ) falciparum erythrocytic stage antigen different period infancy development naturally acquire immunity ( NAI ) . Hypothesis : Exposure P. falciparum prior 5 month age result development NAI , exposure P. falciparum 5 month age lead development NAI . The risk clinical malaria anaemia second year life compare cohort , well correlation type quality immune response ( antibody several P. falciparum antigen , cytokine ) , oxidative stress marker host genetic factor . These result shed light determinant development anti-P. falciparum response early life potential constraint early life immunisation .</brief_summary>
	<brief_title>Age Exposure Immunity Malaria Infants</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>Inclusion criterion pregnant woman : Healthy HIVnegative pregnant female less 50 year age attend voluntary counseling testing ( VCT ) center Maragra Manhiça antenatal clinic , Permanent resident Manhiça area expect live area infant least 2 year . Inclusion criterion newborn infant : Healthy infant , weigh &gt; = 2 kg alive mother . Exclusion criterion pregnant woman : Plan leave area le 2 year start study ; Women willing get test HIV infection VCT center ; Test positive HIV ; Not willing provide inform consent ; Can understand either Portuguese Changana ( consent form write language ) . Exclusion criterion newborn infant : Any obvious congenital malformation ; Any sign cerebral asphyxia ; Any obvious neonatal infection ; Same gender Twins ; Low birth weight ( &lt; 2 kg ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Week</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>natural acquire immunity ,</keyword>
	<keyword>clinical malaria ,</keyword>
	<keyword>P. falciparum ,</keyword>
	<keyword>age ,</keyword>
	<keyword>exposure ,</keyword>
	<keyword>neonatal immunology ,</keyword>
	<keyword>infant</keyword>
</DOC>